Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-678
Closed -$150K 314
2026
Q1
$150K Sell
678
-44
-6% -$10.8K 0.04% 108
2025
Q4
$183K Sell
722
-146
-17% -$36.7K 0.05% 99
2025
Q3
$215K Buy
868
+84
+11% +$20.1K 0.07% 101
2025
Q2
$188K Sell
784
-76
-9% -$17.7K 0.06% 102
2025
Q1
$195K Sell
860
-65
-7% -$14.3K 0.07% 114
2024
Q4
$190K Sell
925
-64
-6% -$14K 0.06% 116
2024
Q3
$240K Sell
989
-35
-3% -$8.19K 0.08% 104
2024
Q2
$225K Buy
1,024
+7
+0.7% +$1.52K 0.08% 105
2024
Q1
$229K Buy
1,017
+344
+51% +$77.6K 0.08% 109
2023
Q4
$148K Hold
673
0.07% 119
2023
Q3
$148K Buy
673
+162
+32% +$36.6K 0.08% 122
2023
Q2
$115K Buy
+511
New +$102K 0.06% 137

Other funds holding STE

Steph & Co's STE Position: Q2 2026 in Review

Steph & Co sold out of Steris (STE) in Q2 2026, closing a stake of 678 shares — an estimated $150K sold.

Steph & Co first reported a position in STE in Q2 2023 and held it in 12 quarters. The position peaked at $240K in Q3 2024. 91 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Steph & Co reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
  • Steph & Co sold 678 Steris shares in Q2 2026, an estimated $150K.
  • Steph & Co first reported a position in Steris in Q2 2023 and held it in 12 quarters.
  • Steph & Co's Steris position peaked at $240K in Q3 2024.
  • 91 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.